期刊文献+

解毒活血方对肾间质纤维化大鼠TGF-β1的影响 被引量:3

Effects of Jieduhuoxue therapy on the TGF-β1 in renal interstitial fibrosis rats
原文传递
导出
摘要 目的:观察解毒活血法对肾间质纤维化大鼠TGF-β1的影响,探讨其抑制肾间质纤维化的作用机制。方法:SD大鼠随机分为假手术组,模型组,缬沙坦组,解毒活血低剂量组,解毒活血高剂量组,每组10只。除假手术组,其余各组大鼠结扎左侧输尿管复制肾间质纤维化模型。所有大鼠灌胃给药,缬沙坦组给予26 mg/kg;解毒活血低剂量组予解毒活血中药12g生药/kg;解毒活血高剂量组予24g生药/kg,假手术组和模型组予等容量生理盐水,共14天。左肾组织行HE、Masson染色,观察病理形态学改变,免疫组化检测肾组织中TGF-β1的蛋白表达。结果:模型组大鼠间质大量炎症细胞浸润,胶原成分明显增多,TGF-β1呈强阳性表达,各治疗组炎症细胞浸润及胶原沉积程度均比模型组显著减轻,TGF-β1表达明显减弱。结论:解毒活血方药可抑制肾组织中TGF-β1的表达,继而减少细胞外基质沉积,延缓肾间质纤维化进程。 Objective:To observe the effects of Jieduhuoxue therapy on the expression of TGF-β1 in UUO rats,and to investigate its mechanism in renal interstitial fibrosis.Methods:Fifty Sprague-Dawley rats were randomized equally into 5 groups:Control group,UUO group,Valsartan group,low-dose of Jieduhuoxue decoction group and high-dose of Jieduhuoxue decoction group.Except the Control group,rats in other four groups were made into renal interstitial fibrosis model by ligaturing the left ureter.All rats were treated with drugs by oral infusion once a day.Rats in Valsartan group,Jieduhuoxue decoction low-dose group and high-dose group were treated respectively with Valsartan 26mg/kg,Jieduhuoxue decoction 12g/kg and 24g/kg for fourteen days.The protein expressions of TGF-β1 in rats' kidney were detected by immunohistochemical.Results:Compared with control group,the inflammatory cells infiltration and collagen deposition of the model group in renal interstitial space increased significantly,the expression of TGF-β1 was enhanced.After treatment,the inflammatory cells infiltration and collagen deposition decreased,the high expression of TGF-β1 was down-regulated.Conclusion:Jieduhuoxue decoction has the effect of inhibiting the over expression of TGF-β1,reducing the deposition of extracelluar matrix,delaying the procedure of renal interstitial fibrosis.
出处 《中药药理与临床》 CAS CSCD 北大核心 2012年第5期169-172,共4页 Pharmacology and Clinics of Chinese Materia Medica
基金 河北省科技支撑计划项目(10276105-D) 河北省中医药管理局科研计划项目(2010005)共同资助
关键词 肾间质纤维化 单侧输尿管梗阻 解毒活血法 转化生长因子-Β1 Jieduhuoxue therapy(解毒活血方) renal interstitial fibrosis unilateral ureteral obstruction TGF-β1
  • 相关文献

参考文献7

  • 1Gupta S, Clarkson MR, Duggan J, et al. Connective tissue growthfac- tor: potential role in grmerulosclerosis and tubularinterstitial fibrosis. Kidney Int, 2000; 58:1389-1399.
  • 2Fine L G, Norman J T. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeuties. Kidney Int, 2008; 74:867-872.
  • 3Kagami S,Border WA,miller DE,et al. Angiotensinllstimulates extra- cellular matrix protein synthsis through induction of transforming growth fae-tor-βexpression in rat glomerular mesangial cells. J Clin Invest, 1994; 93 2431.
  • 4Fefia I, Pichardo 1, Juarez P, et at. Therapeutic benefit of spironolac- tone in experimental chronic cyclosporine A nephrotoxicity. Kidney Int, 2003; 63:43-52.
  • 5Gooch JL, Gorin Y, Zhang BX, et al. Involvement of ealeineurin in transforming growth factor-beta mediated regulation of extra cellular matrix ac- cumulation. J Biol Chem, 2004; 279: 15561 - 15570.
  • 6余健,聂国明,齐曼丽,邹敏书,李琳,罗莉漫,徐洪涛,丁冬胜.BMP-7拮抗系膜细胞TGF-β1诱导MMPs的表达[J].华南国防医学杂志,2011,25(5):402-405. 被引量:6
  • 7Slattyer C, Campbell E, McMoon'w T, et al. Cyclosporine A-induced renal fibrosis: a role for repithelial mesenchymal transition. American Journal of Pathology, 2005 ; 167 (2) : 395 - 407.

二级参考文献14

  • 1Zhang D,Sun L,Xian W,et al.Low-dose paclitaxel ameliorates renal fibrosis in rat UUO model by inhibition of TGF-beta/Smad activity[J].Lab Invest,2010,90(3):436-447.
  • 2Novak KB,Le HD,Christison-Lagay ER,et al.Effects of metalloproteinase inhibition in a murine model of renal ischemiareperfusion injury[J].Pediatr Res,2010,67 (3):257-262.
  • 3Ioannidis I,Dimo B,Karameris A,et al.Comparative study of the immunohistochemical expression of metalloproteinases 2,7and 9 between clearly invasive carcinomas and “in situ” trophoblast invasion[J].Neoplasma,2010,57(1):20-28.
  • 4Phillips AO,Fraser DJ.BMP-7 stops TGF-β in peritoneal fibrosis[J].Nephrol Dial Transplant,2010,25(4):1036-1038.
  • 5Hewitson TD.Renal tubulointerstitial fibrosis:common but never simple[J].Am J Physiol Renal Physiol,2009,296(6):F1239-F1244.
  • 6Catania JM,Chen G,Parrish AR.Role of matrix metalloproteinases in renal pathophysiologies[J].Am J Physiol Renal Physiol,2007,292(3):F905-F911.
  • 7Li Y,Kang YS,Dai C,et al.Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria[J].Am J Pathol,2008,172(2):299-308.
  • 8Liu Y.New insights into epithelial-mesenchymal transition in kidney fibrosis[J].J Am Soc Nephrol,2010,21(2):212-222.
  • 9Li T,Surendran K,Zawaideh MA,et al.Bone morphogenetic protein 7:a novel treatment for chronic renal and bone disease[J].Curr Opin Nephrol Hypertens,2004,13(4):417-422.
  • 10Zeisberg M,Kalluri R.Reversal of experimental renal fibrosis by BMP7 provides insights into novel therapeutic strategies for chronic kidney disease[J].Pediatr Nephrol,2008,23(9):1395-1398.

共引文献5

同被引文献58

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部